T3 Labs Acquired by Veranex

Veranex, a purpose-driven global services platform for the medtech industry, has announced the acquisition of T3 Labs, a highly respected preclinical laboratory based in Atlanta, Georgia. The acquisition reinforces Veranex's commitment to expanding its preclinical footprint in North America, deepening its therapeutic expertise, and providing greater flexibility to its customers. Pat Donnelly, CEO of Veranex, said: "T3 Labs joining the Veranex family advances our mission to integrate the entire medical technology development process from concept to commercialization. The growth of the preclinical market, increasing regulatory requirements, and the need for productive collaboration between customers and product development partners make T3 Labs a strategic fit for Veranex and an incredible asset for our customers." T3 Labs is a leader in preclinical assessment services in the United States, operating a 33,000 square-meter facility with innovative equipment, training facilities, and state-of-the-art operating rooms dedicated to research across 12 therapeutic areas. Located in Science Square, a growing life sciences hub in Atlanta, Georgia, T3 Labs shares strategic community relationships with the Centers for Disease Control and Prevention (CDC), Emory University, Georgia Tech, and others. T3 Labs staff have contributed to the FDA approval of more than 60 products over the past decade, bringing deep preclinical medical device expertise. T3 Labs complements Veranex PCS France, which has a 25-year track record of delivering world-class preclinical services. T3 Labs and Veranex PCS France now provide customers with world-class, turnkey, comprehensive preclinical service offerings. T3 Labs is led by Sherry Farrugia, an entrepreneur and executive leader with more than 30 years of leadership experience in the healthcare and medical device sector, and Dr. Jeff White, a biomedical operations manager with extensive experience in medtech innovation operations. Sherry Farrugia said: "Joining the Veranex family enables T3 Labs to better serve the broader medtech and Science Square community. By combining our expertise and offerings with Veranex's existing preclinical services, we are excited about the impact we can create for our customers and the healthcare sector overall." Dr. Jeff White added: "Veranex maintains very high standards in the services it provides to customers, and that is a shared value with T3 Labs. Together, T3 Labs and Veranex can deliver more integrated, valuable, and specialized services to the medtech community. We look forward to our future contributions." Source